Literature DB >> 27258073

Opioid-induced Hallucinations: A Review of the Literature, Pathophysiology, Diagnosis, and Treatment.

Eellan Sivanesan1, Melvin C Gitlin, Keith A Candiotti.   

Abstract

Despite their association with multiple adverse effects, opioid prescription continues to increase. Opioid-induced hallucination is an uncommon yet significant adverse effect of opioid treatment. The practitioner may encounter patient reluctance to volunteer the occurrence of this phenomenon because of fears of being judged mentally unsound. The majority of the literature concerning opioid-induced hallucinations arises from treatment during end-of-life care and cancer pain. Because the rate of opioid prescriptions continues to increase in the population, the rate of opioid-associated hallucinations may also conceivably increase. With a forecasted increase in the patient-to-physician ratio, opioid therapy is predicted to be provided by practitioners of varying backgrounds and medical specialties. Hence, knowledge of the pharmacology and potential adverse effects of these agents is required. This review seeks to increase awareness of this potential complication through a discussion of the literature, potential mechanisms of action, diagnosis, and treatment strategies.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27258073      PMCID: PMC6482381          DOI: 10.1213/ANE.0000000000001417

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  9 in total

1.  Frequency, Outcomes, and Associated Factors for Opioid-Induced Neurotoxicity in Patients with Advanced Cancer Receiving Opioids in Inpatient Palliative Care.

Authors:  Kyu-Hyoung Lim; Nhu-Nhu Nguyen; Yu Qian; Janet L Williams; Diane D Lui; Eduardo Bruera; Sriram Yennurajalingam
Journal:  J Palliat Med       Date:  2018-09-27       Impact factor: 2.947

Review 2.  Delirium in critical illness: clinical manifestations, outcomes, and management.

Authors:  Joanna L Stollings; Katarzyna Kotfis; Gerald Chanques; Brenda T Pun; Pratik P Pandharipande; E Wesley Ely
Journal:  Intensive Care Med       Date:  2021-08-16       Impact factor: 41.787

Review 3.  Pancreas Cancer-Associated Pain Management.

Authors:  Andrew L Coveler; Jonathan Mizrahi; Bory Eastman; Smith Jim Apisarnthanarax; Shalini Dalal; Terry McNearney; Shubham Pant
Journal:  Oncologist       Date:  2021-05-12

Review 4.  Cancer Pain Management: Opioid Analgesics, Part 2.

Authors:  Rita J Wickham
Journal:  J Adv Pract Oncol       Date:  2017-09-01

Review 5.  The Pharmacology of Visual Hallucinations in Synucleinopathies.

Authors:  Mirella Russo; Claudia Carrarini; Fedele Dono; Marianna Gabriella Rispoli; Martina Di Pietro; Vincenzo Di Stefano; Laura Ferri; Laura Bonanni; Stefano Luca Sensi; Marco Onofrj
Journal:  Front Pharmacol       Date:  2019-12-09       Impact factor: 5.810

6.  Lessons from the Analysis of a Retrospective Cohort of Patients Who Underwent Large Open Abdominal Surgery Under Total Intravenous Opioid-Free Anesthesia.

Authors:  Jean-Pierre Estebe; Mathieu Morel; Timothée Daouphars; Elric Ardant; Chloé Rousseau; Anaïs Drouet; Camille Bosquet; Karim Boudjema
Journal:  Drugs Real World Outcomes       Date:  2020-11-24

7.  Hydromorphone-Induced Tactile Hallucinations: Rare Opioid Side Effect.

Authors:  Miki Kiyokawa; William F Haning
Journal:  Cureus       Date:  2021-02-28

8.  Psychotic Symptoms After SARS-CoV-2 Infection.

Authors:  Gerardo Fiks; Juan Manuel Duarte; Gisela Roxana Lisi; Marcelo Garro; Francisco Appiani
Journal:  J Nerv Ment Dis       Date:  2022-09-01       Impact factor: 1.899

9.  Opioid-Induced Psychosis in a Patient With Sickle Cell Disease.

Authors:  Terence Tumenta; Amod Thanju; Pradilka Perera; Jisha Kallikkadan; Patrice Fouron; Tolulope Olupona
Journal:  Cureus       Date:  2021-06-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.